Showing results (2071-2080 of 2,213) with videos related to
Sort By:
Pageof 222
Trials|March 2, 2018
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) studyPatricia Healy, Sandra Galvin, Paula R Williamson, et al.Brain, Behavior, and Immunity|August 22, 2022
The live biotherapeutic Blautia stercoris MRx0006 attenuates social deficits, repetitive behaviour, and anxiety-like behaviour in a mouse model relevant to autismParomita Sen, Eoin Sherwin, Kiran Sandhu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.Plos Genetics|June 4, 2011
Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissueFederico Innocenti, Gregory M Cooper, Ian B Stanaway, et al.The Journal of Prevention of Alzheimer'S Disease|June 12, 2025
Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathologyCamilo Bermudez, Jeremy A Syrjanen, Nikki H Stricker, et al.Acta Neuropathologica|March 14, 2025
High resolution autoradiography of [18F]MK-6240 and [18F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturitySujala Ghatamaneni, Courtney Coleman, Ian Shin, et al.BMJ Open|July 10, 2024
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)Amanda Ullman, Mari Takashima, Victoria Gibson, et al.Journal of Crohn'S & Colitis|January 9, 2018
Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical RecurrenceCalvin J Coffey, Miranda G Kiernan, Shaheel M Sahebally, et al.Preparative Biochemistry & Biotechnology|May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditionsR Murphy, S Green, G Ritter, et al.Neurology|March 19, 2020
Modeling disease trajectory in Duchenne muscular dystrophyWilliam D Rooney, Yosef A Berlow, William T Triplett, et al.Pageof 222